SANXING(601567)
Search documents
三星医疗(601567.SH)下属子公司签约1.35亿元巴西CPFL智能电表项目合同
智通财经网· 2025-12-24 07:55
Core Viewpoint - Samsung Medical (601567.SH) has signed a contract for the Brazil CPFL smart meter project, marking a significant step in expanding its overseas market presence and localizing its operations [1] Group 1: Contract Details - The contract was signed by Samsung Medical's wholly-owned subsidiary, Brazil Nansen, and involves the supply of single-phase and three-phase smart meters [1] - The total contract amount is 10,590.99 million Brazilian Reais, approximately 135 million RMB [1] - This contract represents about 0.92% of the company's audited revenue for the fiscal year 2024 [1] Group 2: Impact on Business - The execution of this contract is expected to have a positive impact on the company's operational performance and business results [1] - The signing of this contract reflects the company's efforts to actively explore overseas markets and deepen its local layout [1] - The contract will help the company enhance its overseas business layout and improve its competitive advantage in international markets [1]
三星医疗下属子公司签约1.35亿元巴西CPFL智能电表项目合同
Zhi Tong Cai Jing· 2025-12-24 07:53
Core Viewpoint - Samsung Medical (601567.SH) has signed a contract for the Brazil CPFL smart meter project, marking a significant step in expanding its overseas market presence and localizing operations [1] Group 1: Contract Details - The contract was signed by the company's wholly-owned subsidiary, Brazil Nansen, to supply single-phase and three-phase smart meters [1] - The total contract amount is 10,590.99 million Brazilian Reais, approximately 135 million RMB [1] - This contract represents about 0.92% of the company's audited revenue for the fiscal year 2024 [1] Group 2: Impact on Business - The execution of this contract is expected to have a positive impact on the company's operational performance [1] - The contract will not affect the independence of the company's business operations [1] - This signing is a result of the company's efforts to actively explore overseas markets and deepen local layouts, enhancing its competitive advantage in international markets [1]
三星医疗:子公司签订1.35亿人民币海外经营合同
Xin Lang Cai Jing· 2025-12-24 07:50
三星医疗公告,下属全资子公司巴西南森签订巴西CPFL智能电表项目合同,合同金额总计1.06亿雷亚 尔,约合1.35亿人民币,占公司2024年度经审计营业收入的0.92%。公司将提供单相和三相智能电表等 产品。该合同的签订是公司积极拓展海外市场、深化本地化布局的重要成果,有助于提升公司的海外市 场竞争力。合同的履行将对公司经营业绩产生积极影响。 ...
三星医疗:全资子公司签订约1.35亿元海外经营合同
Zheng Quan Shi Bao Wang· 2025-12-24 07:50
人民财讯12月24日电,三星医疗(601567)12月24日公告,下属全资子公司巴西南森签订巴西CPFL智 能电表项目合同,合同金额总计1.06亿雷亚尔,约合1.35亿元人民币,占公司2024年度营业收入的 0.92%。 ...
三星医疗:子公司签订巴西CPFL智能电表项目合同
Ge Long Hui· 2025-12-24 07:48
Group 1 - The core point of the article is that Samsung Medical (601567.SH) has signed a contract for a smart meter project in Brazil with CPFL, amounting to 105.9099 million Brazilian Reais, which is approximately 135 million Chinese Yuan [1] Group 2 - The contract is executed through Nansen Instrumentos de Precisão Ltda, a wholly-owned subsidiary of Samsung Medical [1] - The project signifies Samsung Medical's expansion into the Brazilian market, particularly in the smart meter sector [1] - The financial implications of the contract could enhance the company's revenue and market presence in Latin America [1]
三星医疗:公司主营业务为智能配用电及医疗服务两大板块
Zheng Quan Ri Bao Wang· 2025-12-23 13:52
证券日报网讯12月23日,三星医疗(601567)在互动平台回答投资者提问时表示,公司主营业务为智能 配用电及医疗服务两大板块,未涉及可控核聚变领域。 ...
三星医疗:主营业务为智能配用电及医疗服务两大板块,未涉及可控核聚变领域
Mei Ri Jing Ji Xin Wen· 2025-12-23 12:10
(文章来源:每日经济新闻) 每经AI快讯,有投资者在投资者互动平台提问:贵司是否涉及可控核聚变领域? 三星医疗(601567.SH)12月23日在投资者互动平台表示,公司主营业务为智能配用电及医疗服务两大 板块,未涉及可控核聚变领域。 ...
三星医疗:未涉及可控核聚变领域
Sou Hu Cai Jing· 2025-12-23 11:10
针对上述提问,三星医疗回应称:"尊敬的投资者,您好!公司主营业务为智能配用电及医疗服务两大 板块,未涉及可控核聚变领域。感谢您的关注!" 有投资者在互动平台向三星医疗提问:"贵司是否涉及可控核聚变领域?" 声明:市场有风险,投资需谨慎。本文为AI基于第三方数据生成,仅供参考,不构成个人投资建议。 来源:市场资讯 ...
三星医疗(601567.SH):未涉及可控核聚变领域
Ge Long Hui· 2025-12-23 10:51
格隆汇12月23日丨三星医疗(601567.SH)在投资者互动平台表示,公司主营业务为智能配用电及医疗服 务两大板块,未涉及可控核聚变领域。 ...
宁波三星医疗电气股份有限公司 关于为子公司提供担保的进展公告
Zhong Guo Zheng Quan Bao - Zhong Zheng Wang· 2025-12-20 06:20
Overview of Guarantees - The company has signed a guarantee contract with Bank of Communications for a maximum principal amount of RMB 440 million, effective from December 1, 2025, to December 1, 2030 [1] - The company has also signed a maximum guarantee contract with Agricultural Bank of China for a maximum principal amount of RMB 675 million, effective from December 10, 2025, to December 9, 2028 [1] - The company applied for a letter of guarantee from Standard Chartered Bank for USD 100,000 (approximately RMB 716,200), with an initial validity until April 10, 2026, which has been extended to May 15, 2026 [2] Internal Decision-Making Process - The company’s board of directors approved the guarantee proposals on April 24, 2025, and the annual shareholders' meeting on May 16, 2025, allowing for a total guarantee amount of up to RMB 974.85 million, with RMB 450 million specifically for the subsidiary [2] Financial Health of the Guaranteed Entity - The subsidiary, Aux Smart Technology, has a debt-to-asset ratio of 68.93% as of the end of 2024, indicating a significant level of leverage [2] Details of Guarantee Agreements - The guarantee to Bank of Communications covers all principal debts and associated costs, with a maximum guarantee amount of RMB 440 million [4][5] - The guarantee to Agricultural Bank of China also includes all principal debts and associated costs, with a maximum guarantee amount of RMB 675 million [7][8] Necessity and Reasonableness of Guarantees - The guarantees are deemed necessary to meet the funding needs of the subsidiary and ensure its stable operations, with the company maintaining control over the subsidiary's financial health [9] Board of Directors' Opinion - The board believes that providing guarantees to the subsidiary is based on actual operational needs and that the associated risks are manageable [10] Cumulative Guarantee Amounts - As of the announcement date, the total amount of guarantees provided by the company to its subsidiaries is RMB 975.35 million, which represents 80.73% of the company's net assets attributable to shareholders for the year 2024 [10]